Efficacy and Safety of Sintilimab Combined with Apatinib As Third-Line or above Therapy for Patients with Advanced or Metastatic Gastric Cancer.
ANTI-CANCER DRUGS（2024）
Key words
apatinib,efficacy,gastric cancer,immunotherapy,sintilimab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined